INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)

Name: INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
Uploaded: 2025-11-14T17:00:00+00:00
Description: Jerrold L. Vitek, MD, PhD, Head of the Neurology Department at the University of Minnesota, Minneapolis, MN, provides an overview of the INTREPID clinical

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

MRI Clues to Intracranial Infection: Differentiating Bacterial, Viral, Fungal, and Parasitic CNS Disease
MRI Clues to Intracranial Infection: Differentiating Bacterial, Viral, Fungal, and Parasitic CNS Disease
Imaging & Testing
MRI Clues to Intracranial Infection: Differentiating Bacterial, Viral, Fungal, and Parasitic CNS Disease
Márk Kozák, MD; Máté Sik, MD
Márk Kozák, MD; Máté Sik, MD
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Alzheimer Disease & Dementias
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Understanding Dystonia: A Practical Approach to Diagnosis and Management
Understanding Dystonia: A Practical Approach to Diagnosis and Management
Movement Disorders
Understanding Dystonia: A Practical Approach to Diagnosis and Management
Tiziana De Santis, MD; Steven J. Frucht, MD
Tiziana De Santis, MD; Steven J. Frucht, MD
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Movement Disorders
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Jorge Patino, MD
Jorge Patino, MD